Evolution Wealth Advisors, LLC Aligos Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$11.48 - $17.69 $2,227 - $3,431	-194 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$14.57 - $17.72 $1,792 - $2,179	-123 Reduced 38.8%	194 $3,000
Q1 2021 Apr 20, 2021	BUY	$19.1 - $34.94 $6,054 - $11,075	317 New	317 $7,000

240K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $751M
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.